Bausch Health Companies shares are trading higher after Jefferies upgraded the stock from Hold to Buy and raised its price target from $9 to $16.
Portfolio Pulse from Benzinga Newsdesk
Bausch Health Companies' stock has been upgraded from Hold to Buy by Jefferies, with the price target raised from $9 to $16. This has resulted in the shares trading higher.
September 20, 2023 | 12:40 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Bausch Health Companies' stock has been upgraded by Jefferies, leading to a rise in share prices. The price target has been raised from $9 to $16.
The upgrade from Jefferies is a positive signal for investors, indicating increased confidence in Bausch Health Companies' performance. This has led to an increase in the stock's price. The raised price target also suggests a positive outlook for the stock, further boosting investor confidence.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100